MedTrace Logo

The Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe

NCT06801691 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4500

Last updated 2025-03-03

No results posted yet for this study

Summary

In the EUthyroid2 intervention, measures are being developed and implemented in educational settings across the UK, Germany, Slovenia, the Republic of Cyprus, Bangladesh, and Pakistan to effectively raise awareness of the risks associated with iodine deficiency. Each participating country will employ three measurement points. The intervention will be tailored to the specific contextual characteristics of each implementation site. A process evaluation utilizing a convergent parallel mixed methods design will be conducted, involving surveys of students and teachers, as well as semi-structured interviews.

Conditions

  • Iodine Deficiency

Interventions

OTHER

Experimental: Intervention group

Educational materials: Iodine Feedback Tool, lecture on the topic of iodine and health, booklet, exercises, group assignments and a webpage This is a pre/post intervention with no control group.

Sponsors & Collaborators

  • EU Horizon

    collaborator UNKNOWN

  • UK Research and Innovation

    collaborator OTHER

  • EUthyroid

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
13 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-30
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Bangladesh
  • Cyprus
  • Germany
  • Pakistan
  • Slovenia
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06801691 on ClinicalTrials.gov